West Midlands Health Tech Innovation Accelerator (WMHTIA) exceeds Innovation Accelerator programme targets as private co-investment triples initial investment News highlights: WMHTIA has realised nearly £50m in private co-investment in two years following initial £14.5m grant from the Innovation Accelerator (IA) programme Private investors have provided £36m direct investment into WMHTIA-supported...
Spending Review 2025: What £29bn for the NHS means for life sciences and medtech
Last week’s Spending Review delivered a bold signal of intent from the UK Government: the NHS is central to economic recovery – and technology, innovation, and skills are key to its transformation. 👇 🔹 £29 billion to “get the NHS back on its feet and fit for the future”🔹 Up...
Blüm Technologies Group Ltd Acquires Nexus Digital Technologies
Blüm Technologies Group Ltd Acquires Nexus Digital Technologies, unlocking it's ability to boost patient engagement internationally. Blüm Technologies Group has officially acquired Nexus DT, marking a strategic expansion into the patient engagement and digital health sectors. Blüm Technologies Group specialises in providing comprehensive digital health solutions, including software engineering, AI...
Upperton Pharma Solutions Named One of The Sunday Times Best Places to Work 2025
Upperton Pharma Solutions, a leading Nottingham-based pharmaceutical contract development and manufacturing organisation (CDMO), is proud to announce its recognition as one of The Sunday Times Best Places to Work 2025. This prestigious accolade celebrates organisations across the UK that excel in employee experience and workplace culture. The Sunday Times Best...
Shakespeare Martineau sees double with biotech deal duo
The corporate team at law firm Shakespeare Martineau have completed a duo of deals in the biotech sector this week, raising more than £350,000 for pharmaceutical development company Nuformix and cancer diagnostics developer Cizzle Biotechnology. Long-standing client of the firm, Cizzle Biotechnology has raised £150,000 - through the issue of...
Innovation Builder Cohort Powers Health Breakthroughs Across UK and Beyond
Medilink Midlands is proud to announce the successful launch of Cohort 1 of the Medilink Midlands Innovation Builder (MMIB), a revolutionary programme designed to accelerate the development of high-potential health and medtech ventures across the UK and internationally. Developed in partnership with Christian Kumar, Medilink Midlands' Entrepreneur in Residence, the...
Medilink UK Healthcare Business Awards Winners Announced
The prestigious national Medilink UK Healthcare Business Awards 2025 will celebrate the achievements of some of the most innovative life sciences organisations in the UK, at the iconic London Institute for Healthcare Engineering (LIHE) in London on Thursday 10th July, where eight companies will be presented with their awards by industry leaders....
Exploring the Challenges and Opportunities in the UK HealthTech Sector
Introduction The MedTech and HealthTech sectors play a pivotal role in shaping the future of healthcare systems. These industries are at the forefront of innovation, driving advancements in diagnostics, treatments, and patient care. The HealthTech sector is defined within the report to include: General medical devices; Active implantable medical devices;...
IMed Group scales up growth with new Irish division and top talent
Launch of Irish division IMed EUAR and addition of expert talent drive international expansion and strengthen leadership IMed Group, a leading provider of expert services to the global medical and health technology industry, announces the launch (6 May) of its Irish entity: IMed EUAR, based in Cork, which will work...
Sustainability in Health Technology: What is required and Why
The National Institute for Health and Care Research (NIHR) Invention 4 Innovation programme, and Innovation Observatory is attending the Med-Tech Innovation Expo on 4-5 June (NEC, Hall 2) and will feature Sustainability in Health Technology: What is required and Why. Sustainability is a key consideration in product development and an...